InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+4.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Provost Miriam, Vice-Président Réglementaire. Insider active across 1 company, notably TransMedics Group, Inc.. In total, 11 filings have been recorded. History available since 30 July 2021. The latest transaction was filed on 13 December 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
415 shares@ US$16.141.5% of flowCommon StockSEC:0000950170-23-070835:0
1,785 shares@ US$3.221.3% of flowCommon StockSEC:0000950170-23-046432:0
5,685 shares0Common StockSEC:0000899243-23-005899:0
5,918 shares@ US$38.4653.1% of flowCommon StockSEC:0000899243-22-038601:0
2,600 shares@ US$3.222.1% of flowCommon StockSEC:0000899243-22-038318:0
884 shares@ US$3.220.0001% mcap1.5% of flowCommon StockSEC:0000899243-21-049930:0
884 shares@ US$3.220.6% of flowCommon StockSEC:0000899243-21-049930
5,625 shares@ US$16.140.0018% mcap45.0% of flowCommon StockSEC:0000899243-21-036415:0
5,625 shares@ US$16.1418.9% of flowCommon StockSEC:0000899243-21-036415
2,206 shares@ US$3.220.0001% mcap3.5% of flowCommon StockSEC:0000899243-21-031299:0
2,206 shares@ US$3.221.5% of flowCommon StockSEC:0000899243-21-031299
11 of 11 declarations
About Provost Miriam
Miriam Provost is the VP of US Regulatory & FDA Relations at TransMedics Group, Inc. She oversees regulatory and compliance matters, ensuring that the company meets industry standards. Miriam plays a key role in managing relationships with regulatory agencies and obtaining necessary approvals for TransMedics' products. Her regulatory expertise is a valuable asset to the organization.
